drugset / Trial / NCT02503189

A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's Syndrome

NCT02503189 ↗

Summary

The purpose of this study is to investigate the superiority of KCT-0809 to placebo, and to evaluate safety in dry eye patients with Sjögren's syndrome

Timeline

Start
—
Primary completion
2017-01
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Ozagrel Small molecule — —

Indications